Treatment Optimization and Nephrolithiasis Recurrence Prevention With Interdisciplinary Care - Trial NCT06367894
Access comprehensive clinical trial information for NCT06367894 through Pure Global AI's free database. This phase not specified trial is sponsored by Agnieszka Pozdzik and is currently Recruiting. The study focuses on Kidney Stone. Target enrollment is 164 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Agnieszka Pozdzik
Brugmann University Hospital
Timeline & Enrollment
N/A
Dec 12, 2023
Dec 31, 2024
Primary Outcome
Number of acute renal colics,Number of emergency admissions,Number of surgeries,Number of hospitalizations,Identified genetics abnormalities,Wisconsin questionnaire,Kidney function outcome
Summary
Nearly 10% of the Belgian population suffer from kidney stone disease. Recent reviews
 reported that kidney stones represent an underestimated risk factor for further kidney
 function deterioration. Preventive measures are recommended in lithiases patients to prevent
 the formation of new stones. The individual effects of different medicated prosthetic
 interventions have been documented in clinical trials. However, there is little data on the
 effectiveness of combining these different preventive measures in routine clinical practice
 (real-world context).
 
 Patients with kidney stone disease require a complete metabolic assessment. The three main
 factors contributing to the stone's formation are the patient's metabolism, diet and
 lifestyle. Metabolic work-up is recommended by the American Urology Association to identify
 and correct the factors responsible for urinary stone formation such as hypercalciuria,
 hyperoxaluria, hyperuricuria, hypocitraturia or abnormalities of urinary pH. The metabolic
 work-up includes at minimum the 24h urine test, a blood test and spot urine test. Dietary
 habits and lifestyle are assessed by means of a questionnaire.
 
 The CHU Brugmann Hospital has a specialized multidisciplinary clinic for renal lithiases and
 mineral metabolism. Preventive personalized and interdisciplinary care in CHU Brugmann
 consists of a full metabolic work-up allowing the identification of lithogenic risk factors
 by nephrologists, dietary assessment by specialized dieticians and specific treatment
 protocol associated with regular follow-up.
 
 The aim of this study is to evaluate, in the context of a retrospective single-center cohort
 study, the effect of preventive personalized and interdisciplinary care on the evolution of
 all urinary lithogenic risk factors and the recurrence of kidney stones (rate of renal
 colics, emergency room admissions, and urological interventions).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06367894
Non-Device Trial